Evidence map›Paper›PMID 34127548›Full record

ArticleLife science alliance2021

IL-13 deficiency exacerbates lung damage and impairs epithelial-derived type 2 molecules during nematode infection.

Alistair L Chenery, Silvia Rosini, James E Parkinson, Jesuthas Ajendra, Jeremy A Herrera, Craig Lawless, Brian Hk Chan, P'ng Loke, Andrew S MacDonald, Karl E Kadler and 2 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Providing anFrontiers in microbiology · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Alistair L CheneryWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0001-8755-461X
Silvia RosiniWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0002-7853-9300
James E ParkinsonWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0003-4881-5121
Jesuthas AjendraWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0002-9256-5396
Jeremy A HerreraWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0003-4845-8494
Craig LawlessWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0002-8240-3430
Brian Hk ChanWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0002-9451-4621
P'ng LokeDepartment of Microbiology, NYU Langone Health, New York, NY, USA.ORCID 0000-0002-6211-3292
Andrew S MacDonaldLydia Becker Institute for Immunology and Infection, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0002-5356-1149
Karl E KadlerWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID 0000-0003-4977-4683
Tara E SutherlandLydia Becker Institute for Immunology and Infection, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK tara.sutherland@manchester.ac.uk.ORCID 0000-0001-9334-8206
Judith E AllenWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK judi.allen@manchester.ac.uk.ORCID 0000-0002-3829-066X
Manchester Academic Health Science Centre · GBNYU Langone Health · US

Funding

Medical Research Council MR/K01207X/2Medical Research Council MR/L011840/1MRF_ MRF-009-0002-RG-SUTHEWellcome TrustWellcome Trust 106898/A/15/ZWellcome Trust 110126/Z/15/ZWellcome Trust 203128/Z/16/Z
6 · The paper itself

Abstract

IL-13 is implicated in effective repair after acute lung injury and the pathogenesis of chronic diseases such as allergic asthma. Both these processes involve matrix remodelling, but understanding the specific contribution of IL-13 has been challenging because IL-13 shares receptors and signalling pathways with IL-4. Here, we used

Indexed as

Acute Lung InjuryAnimalsDisease Models, AnimalFemaleGene Expression ProfilingIntercellular Signaling Peptides and ProteinsInterleukin-13MaleMiceNippostrongylusProteomicsStrongylida InfectionsUp-RegulationIntercellular Signaling Peptides and ProteinsInterleukin-13Retnla protein, mouse

Identifiers

PMID34127548
PMCPMC8321663
OpenAlexW3170940557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.